Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :12973732
Publication Date : //

Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.


Many abnormalities detected in the thorax by routine conventional imaging studies are benign, yet all require further evaluation because of the concern for cancer. To address this deficiency and develop a serum biomarker for lung cancer, we designed a matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) based platform to display the proteins present in the serum of patients with or without lung cancer, and then challenged the scientific community to analyze these data with the aim of determining specific ion signal differences among the resulting spectra. The most statistically significant ion peak identified by the various analysis algorithms that differentiated the serum of patients with lung cancer from the serum of individuals without lung cancer was found at m/z 11,702. We identified the protein responsible for this ion peak as serum amyloid A (SAA; M(r) = 11,682.7) by partial purification followed by in-gel digestion and peptide mapping. By enzyme-linked immunosorbent assay, we showed SAA to be present at 286 ng/mL in the serum of cancer patients vs. 34.1 ng/mL in the serum of individuals without cancer. These data suggest that the combination of MALDI-TOF MS and computer analysis can be a powerful tool in the search for serum biomarkers of lung cancer and other diseases.

Authors : Howard Brandon A , Wang Michael Z , Campa Michael J , Corro Christina , Fitzgerald Michael C , Patz Edward F ,

Related products :

Catalog number Product name Quantity
28-376 Matrix-assisted laser desorption ionization-time of flight analysis and examination of protein profiles from the SwissProt database revealed that the previously defined p97 repressor is ZNF224, a zinc 0.1 mg
Lung - LUC481 Lung cancer array, 16 cases covering all the common types of lung cancer paired with uninvolved lung tissues from the same patients. 2mm
Lung - LUD481 Lung cancer array, 16 cases covering all the common types of lung cancer paired with uninvolved lung tissues from the same patients. 2mm
Lung - LUC1502 Lung cancer array, non_overlapping with LUC1501, consists of duplicated 70 cases covering all the common types of lung cancer and 5 cases of normal and other non_malignant lung tissues. 1.1 mm
Lung - LUC961 Lung cancer array consists of duplicated 36 cases covering all the common types of lung cancer and 12 cases of normal and other non_malignant lung tissues. 1.5mm
Lung - LUC1501 Lung cancer array consists of duplicated 70 cases covering all the common types of lung cancer and 5 cases of normal and other non_malignant lung tissues. 1.1 mm
LUC1504 Lung cancer tissue array (small cell lung cancer), 75 cases, 150 samples (1.1mm), set 4 75 Cases
Lung - LUC962 Without overlaping with cancer cases in LUC961, LUC962 consists of further 36 cases in duplicates covering all the common types of lung cancer and 12 cases of normal and other non_malignant lung tis 1.5 mm
LC2085a High_density (188 cases_208 cores), multiple types of lung cancer (I_3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue
LC2085a High-density (188 cases_208 cores), multiple types of lung cancer (I-3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue; ihc Anti-Cytokeratin (CK) confirmed
LC2085b High_density (208 cores), multiple types of lung cancer (grade 1_3) tissue array with normal lung and cancer adjacent tissue, and staging info, 188 cases_208 cores (duplicate of LC2085a)
LC2085b High-density (208 cores), multiple types of lung cancer (grade 1-3) tissue array with normal lung and cancer adjacent tissue, and staging info, 188 cases_208 cores (duplicate of LC2085a); ihc Anti-Cy
25-816 RNF6 contains a RING-H2 finger motif. Deletions and mutations in this gene were detected in esophageal squamous cell carcinoma (ESCC), suggesting that this protein may be a potential tumor suppressor. 0.05 mg
ILNGC-SER Cancer samples: Lung Carcinoma (NSCLC) Serum Each
EIAAB11376 Deleted in lung and esophageal cancer protein 1,Deleted in lung cancer protein 1,DLC1,DLC-1,DLEC1,Homo sapiens,Human
E03L0296 Mouse Lung cancer marker ELISA, Lung cancer marker
E04L0296 Rabbit Lung cancer marker ELISA, Lung cancer marker
E07L0296 Porcine Lung cancer marker ELISA, Lung cancer marker
E03L0296 Mouse Lung cancer marker ELISA,Lung cancer marker 96 Tests/kit
E09L0296 Monkey Lung cancer marker ELISA, Lung cancer marker
E14L0296 Sheep Lung cancer marker ELISA, Lung cancer marker 96 Tests/kit
E06L0296 Goat Lung cancer marker ELISA, Lung cancer marker
E08L0296 Canine Lung cancer marker ELISA, Lung cancer marker
E11L0296 Bovine Lung cancer marker ELISA, Lung cancer marker
E01L0296 Human Lung cancer marker ELISA, Lung cancer marker 96 Tests/kit


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur